Coagulation reference ranges: Difference between revisions
mNo edit summary |
added references |
||
| Line 41: | Line 41: | ||
|} | |} | ||
<nowiki>*</nowiki><small>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.</small> | <nowiki>*</nowiki><small>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.</small> | ||
<small>References:</small> | |||
<small>Northern Haematology Quality Assurance Group. (2017). ''Consensus guidelines: Haematology reference ranges'' (Version 1.0).</small> | |||
Revision as of 14:12, 13 November 2026
| Parameter | Units | Normal range | Therapeutic range |
| INR | Ratio | 0.8 - 1.2 | 2.0 - 3.0* |
| APTT | Seconds | 24-38 | 50 - 85 secs |
| FIBRINOGEN | g/L | 1.5-4.0 | |
| TCT | Seconds | < 21 | |
| TCT + PRSO4 | Seconds | < 25 | |
| D DIMER <50yrs | ug/L | < 500 | |
| D DIMER >50yrs | ug/L | Decade x 10 | |
| FVIII | iu/dl | 50 - 150 |
*The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.
References:
Northern Haematology Quality Assurance Group. (2017). Consensus guidelines: Haematology reference ranges (Version 1.0).